JOHNSON & JOHNSON (JNJ)
Health Care / Pharmaceuticals
$242.90
Middle of the pack. No strong signal either way.
Hold
Score based on 5 of 5 models — high confidence
Key Metrics
Estimated Fair Value
Fair value above market price. EPS grew 91% year-over-year. ROE of 22% signals strong profitability. P/E of 22x is moderate for this quality level.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Neutral
4/9
Buffett
Attractive
Business quality & competitive moat
Graham
Neutral
85% above fair value
Lynch
Neutral
High PEG — growth premium · Slow Grower
Greenblatt
Neutral
Top 25% (rank 16%)
Similar Stocks
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer